Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 8, 2002. The report details specific share repurchase activities executed in accordance with shareholder authority granted at the Annual General Meeting on May 20, 2002.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on capital allocation via share buybacks.
- Repurchase Date 1: November 4, 2002
- Shares Purchased: 800,000 ordinary shares
- Price per Share: 1,214.66p
- Repurchase Date 2: November 6, 2002
- Shares Purchased: 790,000 ordinary shares
- Price per Share: 1,263.48p
Material Changes
The filing reports the cancellation of 1,590,000 ordinary shares in total during the reporting period. No comparative financial data or material changes to operating results are provided in this text.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, risk factors, or contingencies. The transactions were executed under existing shareholder authorization.
Investor Verification Checklist
- Verify the total number of shares remaining in the authorized buyback program after these transactions.
- Confirm the total cash outflow for the 1,590,000 shares purchased.
- Check subsequent filings for the impact of these cancellations on earnings per share (EPS).